Skip to main content
FERMENTA BIOTECH LIMITED logo

FERMENTA BIOTECH LIMITED — Investor Relations & Filings

Ticker · FERMENTA ISIN · INE225B01021 LEI · 335800VNTNWW8G1U9314 BSE.NS Manufacturing
Open in API
Filings indexed 670 across all filing types
Latest filing 2025-07-29 Regulatory Filings
Country IN India
Listing BSE.NS FERMENTA

About FERMENTA BIOTECH LIMITED

https://fermentabiotech.com

Fermenta Biotech Limited is a specialized biotechnology company primarily focused on the development and manufacture of Vitamin D3 (Cholecalciferol). As one of the few vertically integrated manufacturers globally, the company produces Vitamin D3 for diverse applications, including pharmaceuticals, dietary supplements, human nutrition, and animal feed. Beyond its core Vitamin D3 portfolio, the company offers a range of specialty enzymes, particularly for the synthesis of beta-lactam antibiotics, and provides environmental solutions through its biotechnology expertise. Fermenta Biotech emphasizes high-quality standards, maintaining various international certifications for its manufacturing facilities. Its product offerings extend to premixes and value-added formats designed to meet specific formulation requirements. The company serves a global clientele, leveraging its research and development capabilities to innovate in the fields of nutrition and biotechnology.

Recent filings

Filing Released Lang Actions
Press release - Grant of CEP by EDQM
Regulatory Filings Classification · 95% confidence The document is a press release issued by Fermenta Biotech Limited announcing the receipt of a Certificate of Suitability (CEP) from the European Directorate for the Quality of Medicines & Healthcare (EDQM) for one of its products. It is dated July 29, 2025, and includes statements from the Managing Director about the significance of this certification. The document does not contain financial data, regulatory filings, or detailed reports such as annual or quarterly reports. It is a corporate announcement about a regulatory approval related to product certification, not a financial or governance report. The document is also relatively short (6869 characters) and serves as a public announcement. Therefore, it fits best under the category of Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other categories.
2025-07-29 English
Newspaper publication
Regulatory Filings
2025-07-26 English
Newspaper Publication - Notice of 73rd Annual General Meeting - Post dispatch
Regulatory Filings
2025-07-21 English
Certificate under reg. 74(5) of SEBI (DP), Regulation, 2018 for the quarter ended June 30, 2025.
Regulatory Filings Classification · 95% confidence The document is a certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended June 30, 2025. It is a confirmation letter from the company and its registrar and transfer agent regarding the dematerialization of securities and related compliance. The document is short (4161 characters) and primarily serves as a certification or confirmation rather than a full financial report or detailed regulatory filing. It does not contain financial statements or substantive financial data. Therefore, it fits best under Regulatory Filings (RNS) as it is a compliance certificate related to securities dematerialization under SEBI regulations.
2025-07-21 English
Notice of 73rd Annual General Meeting to be held on August 12, 2025.
AGM Information Classification · 100% confidence The document is a Notice of the 73rd Annual General Meeting (AGM) of Fermenta Biotech Limited scheduled for August 12, 2025. It includes details about the meeting agenda such as adoption of audited financial statements, dividend declaration, appointment and re-appointment of directors, and approval of an Employee Stock Option Scheme. The document is addressed to the stock exchange and shareholders, and it explicitly states it is a Notice of AGM. It does not contain the full Annual Report or financial statements themselves but refers to their availability on the company's website. The document length is about 15,000 characters, but the content is clearly a meeting notice rather than the report itself. Therefore, according to the classification rules, this document is best classified as AGM Information (AGM-R).
2025-07-19 English
Business Responsibility and Sustainability Reporting for Financial year ended March 31, 2025.
Environmental & Social Information Classification · 95% confidence The document is a detailed Business Responsibility and Sustainability Report (BRSR) for the financial year 2024-25 submitted by Fermenta Biotech Limited. It includes extensive disclosures on environmental, social, governance practices, employee details, business activities, risks and opportunities related to sustainability, and compliance with national guidelines on responsible business conduct. The document references the BRSR as part of the Annual Report 2024-25 but is itself a standalone report focusing on ESG factors rather than financial performance or management discussion. Given the content and focus on sustainability and responsibility, this document fits the category of Environmental & Social Information (SR). The document length (15,000 characters) and detailed content confirm it is the report itself, not just an announcement or certification.
2025-07-19 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.